跳至主要内容
临床试验/JPRN-UMIN000007690
JPRN-UMIN000007690已完成1 期

Phase I study to evaluate the safety and efficacy of resveratrol in enhancing the function of natural killer cells - Safety and efficacy of resveratrol in enhancing NK activity

Kanazawa University Hospital0 个研究点目标入组 5 人开始时间: 2012年4月9日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
5

研究概览

简要总结

The administration of MES resulted in a significant increase in the antioxidant activity of the plasma and a decrease in the protein carbonyl content of the plasma compared with the corresponding baseline levels. The circulating numbers of B and T lymphocytes remained essentially unchanged throughout the course of the study, however MES consumption was associated with an increase in the proportion of circulating NK cells and regulatory T cells (CD3+, CD4+, CD25, CD127low/neg).

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 60years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Any of the following: currently receiving a drug therapy, currently having chronic diseases such as heart, lung, kidney, gastrointestinal, and inflammatory diseases, suffering from invasive cancer within five years, suffering from non-invasive cancer within a year, and a history of smoking within one year.

研究者

相似试验